Basic Research
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 14, 2005; 11(10): 1515-1520
Published online Mar 14, 2005. doi: 10.3748/wjg.v11.i10.1515
Table 2 Plan of orthogonal trial and the result of Ca2+ assay (mean±SD).
TrialCCl4(mmol/L)Drug serum(mL/L)TGF-β1 Ab(mg/mL)Time(h)TurnFluorescence intensity
TGF-β1 AbDrug serum
15550.5181.03±7.3678.25±6.84
21520200.51126.52±13.54109.38±15.63
3510102175.84±6.8172.54±9.52
41020202.01106.46±10.2388.65±10.38
5105541117.65±9.26102.13±12.45
615101041138.24±12.57113.36±11.82
71010100.5294.53±8.6784.47±8.23
81510100.52128.67±11.5696.48±9.65
9155522138.21±14.83118.65±12.34
10520202262.17±6.5850.16±6.48
1110554.02114.28±8.3792.54±8.75
12520204264.23±5.2646.23±3.64